ResearcherJuntendo UniversityActive in the last 2 years

Hadrien Charvat

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3624-1394; OpenAlex author ID A5090992712. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Projection of the number of new cases of pancreatic cancer in the world. First author DOI 10.1093/jjco/hyae071 ↗
Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan. Co-author DOI 10.1158/1055-9965.epi-21-0808 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kumiko Saika · 1 shared paper, 2024 · strength 0.46
- Paper Projection of the number of new cases of pancreatic cancer in the world. DOI 10.1093/jjco/hyae071 ↗
Enbo Ma · 1 shared paper, 2022 · strength 0.14
- Paper Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan. DOI 10.1158/1055-9965.epi-21-0808 ↗
Norie Sawada · 1 shared paper, 2022 · strength 0.14
- Paper Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan. DOI 10.1158/1055-9965.epi-21-0808 ↗
Manami Inoue · 1 shared paper, 2022 · strength 0.14
- Paper Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan. DOI 10.1158/1055-9965.epi-21-0808 ↗
Shoichiro Tsugane · 1 shared paper, 2022 · strength 0.14
- Paper Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan. DOI 10.1158/1055-9965.epi-21-0808 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.